Wangbing Chen
- Topics
- RNA modifications and cancer (4 papers)Genomics and Chromatin Dynamics (4 papers)Bioactive Compounds and Antitumor Agents (3 papers)
- Journals
- PLoS ONEMolecular CancerMedicine
- Partner nations
- ChinaUnited States
In The Last Decade
Wangbing Chen
20 papers receiving 762 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 479
- Endocrine and Autonomic Systems 158
- Cancer Research 154
- Oncology 109
- Pharmacology 82
Countries citing papers authored by Wangbing Chen
This map shows the geographic impact of Wangbing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangbing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangbing Chen more than expected).
Fields of papers citing papers by Wangbing Chen
This network shows the impact of papers produced by Wangbing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangbing Chen. The network helps show where Wangbing Chen may publish in the future.
Co-authorship network of co-authors of Wangbing Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Wangbing Chen. A scholar is included among the top collaborators of Wangbing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangbing Chen. Wangbing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 7 | |
| 3 | 2 | |
| 4 | 11 | |
| 5 | 14 | |
| 6 | 18 | |
| 7 | 41 | |
| 8 | 19 | |
| 9 | 24 | |
| 10 | 33 | |
| 11 | 14 | |
| 12 | 13 | |
| 13 | 19 | |
| 14 | 57 | |
| 15 | 59 | |
| 16 | 100 | |
| 17 | 29 | |
| 18 | 79 | |
| 19 | 62 | |
| 20 | 163 |
About Wangbing Chen
Wangbing Chen is a scholar working on Toxicology, Cancer Research and Oncology, having authored 20 papers that have together received 769 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Genomics and Chromatin Dynamics (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (158 citations), Cancer Research (154 citations) and Biological Psychiatry (24 citations). Wangbing Chen has collaborated with scholars based in China and United States. Frequent co-authors include Wuguo Deng, Wenlin Huang, Dingbo Shi, Lingyi Fu, Jingshu Wang, Wei Guo, Tiebang Kang, Xiangsheng Xiao, Wendan Yu and Liqun Liu. Their work appears in journals such as PLoS ONE, Molecular Cancer and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.